Institutional representatives, researchers and healthcare experts come together to discuss a national strategy for predictive and personalised medicine. The HEAL Italia Foundation presents a long-term vision extending beyond Italy’s National Recovery and Resilience Plan (PNRR), with the aim of translating scientific innovation into tangible opportunities for prevention and treatment for all citizens.
Rome, 6 October 2026 – From medicine for all to medicine tailored to each individual. This is the guiding principle behind the “HEAL Italia 2036” White Paper, presented by the HEAL Italia Foundation in the Refectory Hall of Palazzo San Macuto, at the Chamber of Deputies. The strategic document brings together the expertise, infrastructure and achievements developed through Italy’s National Recovery and Resilience Plan (PNRR) and sets out a national pathway towards making Precision Medicine an integral part of the Italian National Health Service.
The presentation brought together representatives of public institutions, academia and the scientific research community, reaffirming the importance of dialogue between policymakers, innovators and the healthcare system.
Instituzional Greetings
The proceedings were opened by Giorgio Mulè, Vice-President of the Chamber of Deputies, who acknowledged HEAL Italia’s work as an exceptional opportunity to strengthen national competitiveness and enhance the value of Italian research. “The future of HEAL Italia is a matter of national importance,” Mulè stated, emphasising the responsibility of public institutions to support the transition from scientific innovation to its practical application.
The institutional discussion also featured Massimo Dell’Utri, Undersecretary of State at the Ministry of Foreign Affairs and International Cooperation, who reaffirmed the Government’s commitment to supporting the Foundation’s international outreach. “The Government stands alongside the Foundation,” he declared, highlighting the importance of fostering new opportunities for dialogue and collaboration with the international research community.
Among the institutional representatives in attendance was Fabrizio Cobis, responsible for PNRR funding at the Ministry of University and Research.
Massimo Midiri, President of the HEAL Italia Foundation and Rector of the University of Palermo, outlined the scientific and strategic significance of the White Paper, highlighting the potential of technologies such as genomic sequencing, liquid biopsy, digital diagnostics and wearable devices to transform prevention, diagnosis and personalised treatment.
“HEAL Italia aims to be the driving force behind this transformation,” Midiri emphasised, describing the Foundation’s role as a bridge between scientific research, clinical validation and healthcare practice.
Opening remarks
The operational perspectives outlined in the document were presented by Laura Leonardis, Director General of the HEAL Italia Foundation, who stressed the need to ensure the long-term sustainability of the ecosystem established through the PNRR by consolidating scientific networks, ensuring access to research infrastructure and facilitating the translation of research findings into practical applications.
Particular attention was devoted to the Precision Medicine Plan for Southern Italy, conceived as an integral component of the national strategy. “Not a separate policy, but a means of ensuring that new technologies do not widen existing disparities,” Leonardis clarified.
Further scientific insights were provided by Mauro Piacentini, Scientific Director of the Foundation, who emphasised the importance of building an ecosystem capable of translating scientific knowledge into tangible benefits for citizens. The programme also included a contribution from Giovanni Blandino, Scientific Director of the Regina Elena National Cancer Institute, focusing on the potential applications of liquid biopsy in the diagnosis and monitoring of cancer.
Panels
Medicine with a Vision for the Future
The HEAL Italia 2036 White Paper sets out a roadmap for the 2027–2030 period, built around a shared national governance framework, the interoperability of clinical and genomic data, the strengthening of research infrastructure and the progressive integration of innovative approaches into clinical care. The presentation at the Chamber of Deputies therefore marks a significant milestone in the Foundation’s development: transforming research achievements into a sustainable, long-term strategy for Italy, advancing an increasingly predictive, personalised and accessible model of healthcare in which innovation translates into meaningful opportunities to improve the health and well-being of every individual.
